CN115812959A - Protein peptide glucose-benefiting composition and preparation method thereof - Google Patents
Protein peptide glucose-benefiting composition and preparation method thereof Download PDFInfo
- Publication number
- CN115812959A CN115812959A CN202211632018.4A CN202211632018A CN115812959A CN 115812959 A CN115812959 A CN 115812959A CN 202211632018 A CN202211632018 A CN 202211632018A CN 115812959 A CN115812959 A CN 115812959A
- Authority
- CN
- China
- Prior art keywords
- parts
- extract
- composition
- tablet
- benefiting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 96
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 36
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 36
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 239000000284 extract Substances 0.000 claims abstract description 89
- 239000000843 powder Substances 0.000 claims abstract description 34
- 230000007246 mechanism Effects 0.000 claims abstract description 16
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 14
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 14
- 241000209140 Triticum Species 0.000 claims abstract description 14
- 235000021307 Triticum Nutrition 0.000 claims abstract description 14
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 13
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 13
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 13
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 13
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 13
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 13
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 13
- 241000199919 Phaeophyceae Species 0.000 claims abstract description 13
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 13
- 235000008434 ginseng Nutrition 0.000 claims abstract description 13
- 235000013976 turmeric Nutrition 0.000 claims abstract description 13
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 11
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 11
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 11
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 11
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 11
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 11
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 11
- 239000000600 sorbitol Substances 0.000 claims abstract description 11
- 229940067866 dandelion extract Drugs 0.000 claims abstract description 10
- 235000020691 dandelion extract Nutrition 0.000 claims abstract description 10
- 229920000609 methyl cellulose Polymers 0.000 claims abstract description 10
- 239000001923 methylcellulose Substances 0.000 claims abstract description 10
- 235000010981 methylcellulose Nutrition 0.000 claims abstract description 10
- 239000001845 taraxacum officinale leaf extract Substances 0.000 claims abstract description 10
- 244000197580 Poria cocos Species 0.000 claims abstract description 9
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 9
- 241000756042 Polygonatum Species 0.000 claims abstract description 8
- 239000009429 Ginkgo biloba extract Substances 0.000 claims abstract description 7
- 229940068052 ginkgo biloba extract Drugs 0.000 claims abstract description 7
- 235000020686 ginkgo biloba extract Nutrition 0.000 claims abstract description 7
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract description 3
- 239000004615 ingredient Substances 0.000 claims abstract description 3
- 238000003825 pressing Methods 0.000 claims description 39
- 239000008187 granular material Substances 0.000 claims description 32
- 239000002994 raw material Substances 0.000 claims description 13
- 238000001035 drying Methods 0.000 claims description 12
- 239000002245 particle Substances 0.000 claims description 12
- 238000005469 granulation Methods 0.000 claims description 11
- 230000003179 granulation Effects 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 229920002752 Konjac Polymers 0.000 claims description 10
- 244000056139 Brassica cretica Species 0.000 claims description 9
- 235000003351 Brassica cretica Nutrition 0.000 claims description 9
- 235000003343 Brassica rupestris Nutrition 0.000 claims description 9
- 235000009811 Momordica charantia Nutrition 0.000 claims description 9
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims description 9
- 235000010460 mustard Nutrition 0.000 claims description 9
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 claims description 8
- 235000010485 konjac Nutrition 0.000 claims description 8
- 235000013312 flour Nutrition 0.000 claims description 7
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 6
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 239000000252 konjac Substances 0.000 claims description 6
- 238000004806 packaging method and process Methods 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 6
- 235000011201 Ginkgo Nutrition 0.000 claims description 5
- 244000194101 Ginkgo biloba Species 0.000 claims description 5
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 5
- 241000208340 Araliaceae Species 0.000 claims 3
- 244000078912 Trichosanthes cucumerina Species 0.000 claims 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 abstract description 4
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 39
- 210000004369 blood Anatomy 0.000 description 39
- 241000699670 Mus sp. Species 0.000 description 17
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 14
- 230000000694 effects Effects 0.000 description 12
- 240000004371 Panax ginseng Species 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 8
- 102000004877 Insulin Human genes 0.000 description 7
- 108090001061 Insulin Proteins 0.000 description 7
- 244000302512 Momordica charantia Species 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 229940125396 insulin Drugs 0.000 description 7
- 230000001603 reducing effect Effects 0.000 description 6
- 240000000249 Morus alba Species 0.000 description 5
- 235000008708 Morus alba Nutrition 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 241001633680 Polygonatum odoratum Species 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 239000003472 antidiabetic agent Substances 0.000 description 2
- 235000020230 cinnamon extract Nutrition 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
- 229940077274 Alpha glucosidase inhibitor Drugs 0.000 description 1
- 229940123208 Biguanide Drugs 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- YZJSUQQZGCHHNQ-UHFFFAOYSA-N Homoglutamine Chemical compound OC(=O)C(N)CCCC(N)=O YZJSUQQZGCHHNQ-UHFFFAOYSA-N 0.000 description 1
- 102000003746 Insulin Receptor Human genes 0.000 description 1
- 108010001127 Insulin Receptor Proteins 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 1
- 235000018365 Momordica dioica Nutrition 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003888 alpha glucosidase inhibitor Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 150000004283 biguanides Chemical class 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940046374 chromium picolinate Drugs 0.000 description 1
- GJYSUGXFENSLOO-UHFFFAOYSA-N chromium;pyridine-2-carboxylic acid Chemical compound [Cr].OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1.OC(=O)C1=CC=CC=N1 GJYSUGXFENSLOO-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A protein peptide glucose-benefiting composition and a preparation method thereof comprise a composition A and a composition B, wherein the composition A comprises the following components: ginseng powder, oat beta-glucan, turmeric, wheat oligopeptide, earthworm protein and brown algae extract; composition B consisted of the following ingredients: sorbitol, alkyl propyl methyl cellulose, polyethylene glycol, rhizoma Amorphophalli powder, fructus Momordicae Charantiae extract, herba Ixeritis Sonchifoliae extract, rhizoma Amorphophalli extract, and rhizoma Amorphophalli extract cinnamon powder, kudzu root extract, ginkgo biloba extract, dandelion extract, polygonatum extract and poria cocos extract. In the invention, the tablet A is wrapped by the tablet B, after the tablet B is taken by a human body, the effective components in the tablet B are firstly absorbed by the human body, then the effective components in the tablet A are absorbed by the human body, the tablet A and the tablet B contain active components with different regulating effects, and different regulating mechanisms are used for coordination, thereby playing the role of slow release and long acting.
Description
Technical Field
The invention relates to the field of glucose-benefiting conditioning, in particular to a protein peptide glucose-benefiting composition and a preparation method thereof.
Background
Diabetes is a chronic metabolic disease caused by insulin deficiency, is a current worldwide health problem, the prevalence rate of diabetes in China also increases year by year, newly added patients are mainly type 2 diabetes, and oral hypoglycemic drugs play an important role in the treatment of the patients. Chronic diseases are continuously increased, the incidence of diabetes is continuously improved, the health of old people is directly influenced, and the blood sugar of middle-aged people is over standard due to frequent night stay and drinking of the middle-aged people due to the change of pressure and life style, so that the inconvenience is brought to life and work.
In recent years, biguanides, alpha-glucosidase inhibitors and the like, as well as insulin, immunosuppressants and the like are commonly used clinical hypoglycemic drugs. Although the western medicine has obvious effect of controlling blood sugar, the western medicine generally lacks the overall curative effect, is not beneficial to long-term use and has obvious toxic and side effects.
The invention patent with publication number CN105616958A discloses a blood sugar reducing composition, a blood sugar reducing health food and a preparation method and application thereof, wherein the effective components of the composition are mulberry leaf extract, astragalus extract, sealwort extract, kudzu root extract, chromium picolinate, oligosaccharide and L-arabinose, but the effect is not obvious when the composition is used as an edible blood sugar reducing medicine.
The invention patent with publication number CN104082742A discloses a functional food for conditioning blood sugar balance, which is prepared from the following raw materials in parts by weight: 30-50 parts of mulberry leaf extract, 30-50 parts of cinnamon extract, 5-10 parts of vitamin C and 5-10 parts of vitamin E. The functional food can lower blood sugar under the coordination of the mulberry leaf extract and the cinnamon extract, but the medicine can only inhibit the blood sugar from rising from two aspects, and has a general effect.
Disclosure of Invention
The invention aims to provide a protein peptide glucose-benefiting composition and a preparation method thereof, which adopt the synergistic effect of various compositions with active ingredients and can reduce blood sugar as a food glucose-benefiting composition.
The technical scheme adopted by the invention for realizing the purpose is as follows: a protein peptide glucose-benefiting composition comprises a composition A and a composition B, wherein the composition A comprises the following components: ginseng powder, oat beta-glucan, turmeric, wheat oligopeptide, earthworm protein and brown algae extract; composition B consisted of the following ingredients: sorbitol, alkyl propyl methyl cellulose, polyethylene glycol, rhizoma Amorphophalli powder, fructus Momordicae Charantiae extract, herba Picrasmae extract, cortex Cinnamomi powder, radix Puerariae extract, semen Ginkgo extract, herba Taraxaci extract, rhizoma Polygonati Odorati extract, and Poria extract.
The composition A comprises the following components in parts by weight: 5-10 parts of ginseng powder, 12-16 parts of oat beta-glucan, 6-11 parts of turmeric, 7-13 parts of wheat oligopeptide, 15-20 parts of earthworm protein and 18-26 parts of brown algae extract.
Preferably, the composition A consists of the following components in parts by weight: 7 parts of ginseng powder, 14 parts of oat beta-glucan, 6 parts of turmeric, 10 parts of wheat oligopeptide, 20 parts of earthworm protein and 25 parts of brown algae extract.
In the invention, the composition B comprises the following components in parts by weight: 4-8 parts of sorbitol, 2-6 parts of alkyl propyl methyl cellulose, 1-3 parts of polyethylene glycol, 10-15 parts of konjac powder, 7-10 parts of bitter gourd extract, 13-19 parts of bitter mustard extract, 5-10 parts of cinnamon powder, 9-13 parts of kudzu root extract, 8-16 parts of ginkgo extract, 16-20 parts of dandelion extract, 22-26 parts of polygonatum extract and 17-20 parts of poria extract.
Preferably, the composition B consists of the following components in parts by weight: 5 parts of sorbitol, 4 parts of hydrocarbon propyl methyl cellulose, 3 parts of polyethylene glycol, 11 parts of konjaku flour, 7 parts of balsam pear extract, 19 parts of bitter mustard extract, 9 parts of cinnamon powder, 12 parts of kudzuvine root extract, 15 parts of ginkgo biloba extract, 20 parts of dandelion extract, 22 parts of polygonatum odoratum extract and 18 parts of poria cocos extract.
A preparation method of a protein peptide glucose-benefiting composition comprises the following steps: step one, crushing, mixing and sieving raw materials of the composition A by a 80-mesh sieve, putting the mixture into a swing granulator for granulation to obtain granules A, and drying the granules A for later use;
step two, after the raw materials of the composition B are crushed, mixed and sieved by a 80-mesh sieve, granulating in a swing granulator to obtain granules B, and drying for later use;
step three, taking the mass ratio of 1-1.5:1, adding half weight of the particles B into a pressing mechanism according to the mass ratio, pressing into B tablets, adding the particles A according to the mass ratio, pressing into A + B tablets, adding the rest weight of the particles B, pressing into B + A + B tablets, coating, packaging, inspecting and warehousing.
Furthermore, the pressing mechanism comprises a rack, an upper rotary disc and a lower rotary disc which are driven by the same power source, a feed port is arranged on the rack, a pressing cavity which is arranged corresponding to the feed port is arranged on the upper rotary disc, and the feed port consists of a feed port A and a feed port B; the upper pressure rod and the lower pressure rod are respectively arranged corresponding to the same pressure cavity, so that the upper pressure rod and the lower pressure rod can be pressed into the pressure cavity and matched with the pressure cavity in shape.
The center of the upper rotary table and the center of the lower rotary table are connected with the same rotating shaft, and the rotating shaft is driven by the same power source to rotate so as to drive the upper rotary table and the lower rotary table to synchronously rotate.
Preferably, the feed inlet A and the feed inlet B are respectively and correspondingly connected with a feed pipe A and a feed pipe B.
Preferably, the lower rotating disc is further provided with a fan, an air outlet of the fan is arranged corresponding to the lowest position of the lower pressure head, the pressing mechanism further comprises a lower hopper, and the lower hopper is arranged corresponding to the outer edge of the lower rotating disc.
The B tablet is composed of konjak powder, a bitter gourd extract, a bitter mustard extract, cinnamon powder, a kudzu root extract, a ginkgo biloba extract, a dandelion extract, a polygonatum odoratum extract and a poria cocos extract, the konjak powder can be used as a meal replacement, is rich in dietary fibers, can effectively reduce postprandial blood sugar and reduce the burden of pancreas, the cinnamon powder has an improvement effect on the function of insulin, can help to transport glucose, increase the secretion of insulin and reduce the blood sugar in vivo, and the traditional Chinese medicine extract has the effects of reducing the blood sugar, improving the insulin resistance and inhibiting the beta cell apoptosis of pancreatic islets, and also has the biological activities of improving immunity, resisting aging and the like, and is used for resisting sugar cooperatively. In the ginseng powder, oat beta-glucan, turmeric, wheat oligopeptide, earthworm protein and brown algae extract of the A tablet, the brown algae extract has an antioxidation effect, and the antioxidation effect is improved by cooperating with the ginseng powder and the turmeric to improve the scavenging effect on free radicals; in addition, the oat beta-glucan has a certain effect of reducing blood sugar, the wheat oligopeptide contains oligomethionine, can promote the secretion of insulin and regulate blood sugar, the wheat oligopeptide also contains homoglutamine, can regulate nerves, can reduce the digestive burden without increasing the stomach and intestine, and the earthworm protein can improve the body environment, promote the recovery of pancreatic island function and help to reduce blood sugar.
In the invention, the tablet A is wrapped by the tablet B, after the tablet B is taken by a human body, the effective components in the tablet B are firstly absorbed by the human body, then the effective components in the tablet A are absorbed by the human body, the tablet A and the tablet B contain active components with different regulating effects, different regulating mechanisms are used for coordination, the sustained-release and long-acting effects are achieved, and the drug effect can be achieved for more than 12 hours.
Drawings
FIG. 1 is a schematic view of a pressing mechanism according to the present invention.
The labels in the figure are: 1. the device comprises a rack, 2, an upper rotary table, 3, a lower rotary table, 4, a rotary shaft, 5, a pressure cavity, 6, feed inlets A,7, feed inlets B,8, feed pipes A,9, feed pipes B,10, an upper pressure rod, 11, an upper pressure head, 12, a lower pressure rod, 13, a lower pressure head, 14, a fan, 15, a lower hopper, 16 and composition tablets.
Detailed Description
In order to improve diabetics and sub-healthy people with blood sugar exceeding the standard, research and development teams configure and effectively improve and reduce the blood sugar according to the theory of traditional Chinese medicine, so that the nutritional food for body balance is achieved, and the health level of middle-aged and old people is improved. The invention can be absorbed by human body more easily and fully, and can improve the effective utilization rate of insulin to regulate blood sugar by activating insulin and insulin receptor, thereby realizing the purpose of expressing blood sugar according to the normal physiological natural law of human body and playing an important role in the recovery period of diabetes patients.
The single tablet 0.6g and 18h can release about 90 percent of drug-loading amount after being taken once after breakfast every day, and the frequency of taking the drug is reduced.
The extract of the invention is obtained in one of the following extraction modes: extraction modes such as leaching extraction, enzymolysis ultrasonic extraction, ultrahigh pressure extraction, subcritical extraction and the like.
Example 1
A protein peptide glucose-benefiting composition comprises a composition A and a composition B, wherein the composition A comprises the following components: 7 parts of ginseng powder, 14 parts of oat beta-glucan, 6 parts of turmeric, 10 parts of wheat oligopeptide, 20 parts of earthworm protein and 25 parts of brown algae extract. The composition B comprises the following components in parts by weight: 5 parts of sorbitol, 4 parts of alkyl propyl methyl cellulose, 3 parts of polyethylene glycol, 11 parts of konjac flour, 7 parts of bitter gourd extract, 19 parts of bitter mustard extract, 9 parts of cinnamon powder, 12 parts of kudzu root extract, 15 parts of ginkgo biloba extract, 20 parts of dandelion extract, 22 parts of polygonatum extract and 18 parts of poria cocos extract.
A preparation method of a protein peptide glucose-benefiting composition comprises the following steps: step one, crushing, mixing and screening raw materials of the composition A through a 80-mesh sieve, putting the mixture into a swing granulator for granulation to obtain granules A, and drying the granules A for later use;
step two, crushing, mixing and sieving the raw materials of the composition B by a sieve of 80 meshes, putting the mixture into a swing granulator for granulation to obtain granules B, and drying the granules B for later use;
step three, taking the mass ratio of 1:1, adding half weight of the granules B into a pressing mechanism according to the mass ratio, pressing into tablets B, adding the granules A according to the mass ratio, pressing into tablets A + B, adding the rest weight of the granules B, pressing into tablets B + A + B, coating, packaging, inspecting and warehousing.
Example 2
A protein peptide glucose-benefiting composition comprises a composition A and a composition B, wherein the composition A comprises the following components: 5 parts of ginseng powder, 15 parts of oat beta-glucan, 7 parts of turmeric, 11 parts of wheat oligopeptide, 15 parts of earthworm protein and 20 parts of brown algae extract. The composition B comprises the following components in parts by weight: 4 parts of sorbitol, 2 parts of alkyl propyl methyl cellulose, 1 part of polyethylene glycol, 10 parts of konjac flour, 8 parts of bitter gourd extract, 12 parts of mulberry powder, 15 parts of bitter mustard extract, 5 parts of cinnamon powder, 10 parts of kudzu root extract, 10 parts of ginkgo extract, 17 parts of dandelion extract, 23 parts of polygonatum extract and 20 parts of poria cocos extract.
A preparation method of a protein peptide glucose-benefiting composition comprises the following steps: step one, crushing, mixing and screening raw materials of the composition A through a 80-mesh sieve, putting the mixture into a swing granulator for granulation to obtain granules A, and drying the granules A for later use;
step two, crushing, mixing and sieving the raw materials of the composition B by a sieve of 80 meshes, putting the mixture into a swing granulator for granulation to obtain granules B, and drying the granules B for later use;
step three, taking the mass ratio of 1:1.2, adding half weight of the particles B into a pressing mechanism according to the mass ratio, pressing into B tablets, adding the particles A according to the mass ratio, pressing into A + B tablets, adding the rest weight of the particles B, pressing into B + A + B tablets, coating, packaging, inspecting and warehousing.
Example 3
A protein peptide glucose-benefiting composition comprises a composition A and a composition B, wherein the composition A comprises the following components: 9 parts of ginseng powder, 16 parts of oat beta-glucan, 10 parts of turmeric, 13 parts of wheat oligopeptide, 16 parts of earthworm protein and 18 parts of brown algae extract. The composition B comprises the following components in parts by weight: 6 parts of sorbitol, 1 part of alkyl propyl methyl cellulose, 2 parts of polyethylene glycol, 12 parts of konjac flour, 10 parts of bitter gourd extract, 14 parts of bitter mustard extract, 6 parts of cinnamon powder, 9 parts of kudzu root extract, 8 parts of ginkgo biloba extract, 16 parts of dandelion extract, 26 parts of polygonatum extract and 17 parts of poria cocos extract.
A preparation method of a protein peptide glucose-benefiting composition comprises the following steps: step one, crushing, mixing and screening raw materials of the composition A through a 80-mesh sieve, putting the mixture into a swing granulator for granulation to obtain granules A, and drying the granules A for later use;
step two, crushing, mixing and sieving the raw materials of the composition B by a sieve of 80 meshes, putting the mixture into a swing granulator for granulation to obtain granules B, and drying the granules B for later use;
step three, taking the mass ratio of 1:1.3, adding half weight of the granules B into a pressing mechanism according to the mass ratio, pressing into tablets B, adding the granules A according to the mass ratio, pressing into tablets A + B, adding the granules B with the rest weight, pressing into tablets B + A + B, coating, packaging, inspecting and warehousing.
Example 4
A protein peptide glucose-benefiting composition comprises a composition A and a composition B, wherein the composition A comprises the following components: 10 parts of ginseng powder, 12 parts of oat beta-glucan, 11 parts of turmeric, 7 parts of wheat oligopeptide, 17 parts of earthworm protein and 26 parts of brown algae extract. The composition B comprises the following components in parts by weight: 8 parts of sorbitol, 3 parts of hydrocarbon propyl methyl cellulose, 1 part of polyethylene glycol, 14 parts of konjac flour, 9 parts of bitter gourd extract, 15 parts of mulberry powder, 13 parts of bitter mustard extract, 10 parts of cinnamon powder, 11 parts of kudzu root extract, 16 parts of ginkgo biloba extract, 18 parts of dandelion extract, 25 parts of polygonatum extract and 17 parts of poria cocos extract.
A preparation method of a protein peptide glucose-benefiting composition comprises the following steps: step one, crushing, mixing and screening raw materials of the composition A through a 80-mesh sieve, putting the mixture into a swing granulator for granulation to obtain granules A, and drying the granules A for later use;
step two, crushing, mixing and sieving the raw materials of the composition B by a sieve of 80 meshes, putting the mixture into a swing granulator for granulation to obtain granules B, and drying the granules B for later use;
step three, taking the mass ratio of 1:1.5, adding half of the weight of the granules B into a pressing mechanism according to the mass ratio, pressing into tablets B, adding the granules A according to the mass ratio, pressing into tablets A + B, adding the rest weight of the granules B, pressing into tablets B + A + B, coating, packaging, inspecting and warehousing.
1. The device comprises a rack, 2, an upper rotary table, 3, a lower rotary table, 4, a rotary shaft, 5, a pressure cavity, 6, feed inlets A,7, feed inlets B,8, feed pipes A,9, feed pipes B,10, an upper pressure rod, 11, an upper pressure head, 12, a lower pressure rod, 13, a lower pressure head, 14, a fan, 15, a lower hopper, 16 and composition tablets.
In each embodiment, as shown in fig. 1, the pressing mechanism includes a frame 1, an upper turntable 2 and a lower turntable 3 driven by the same power source, the upper turntable 2 and the lower turntable 3 located under the upper turntable 2 are connected to the same center of the upper turntable 2 and the lower turntable 3, and the same power source drives the same rotation shaft 4 to rotate, so as to drive the upper turntable 2 and the lower turntable 3 to rotate synchronously. The frame 1 is provided with a feed inlet, the upper turntable 2 is provided with a pressure cavity 5 correspondingly arranged with the feed inlet, the feed inlet is composed of a feed inlet A6 and a feed inlet B7, and the feed inlet A6 and the feed inlet B7 are correspondingly connected with a feed pipe A8 and a feed pipe B9 respectively.
Wherein, be equipped with depression bar 10 on the frame 1, the lower extreme of going up depression bar 10 is equipped with pressure head 11, is equipped with depression bar 12 down on the lower carousel 3, and the upper end of depression bar 12 is equipped with pressure head 13 down, goes up depression bar 10 and pressure bar 12 down and corresponds the setting with same pressure chamber 5 respectively, makes pressure head 11 and pressure head 13 can impress pressure chamber 5 and with the shape phase-match in pressure chamber 5 down. The lower rotary disc 3 is further provided with a fan 14, an air outlet of the fan 14 is arranged corresponding to the lowest position of the lower pressing head 13, the pressing mechanism further comprises a lower hopper 15, the lower hopper 15 is arranged corresponding to the outer edge of the lower rotary disc 3, and the fan 14 is enabled to work to blow the composition tablets 16 borne on the lower pressing head 13 down into the lower hopper 15.
The working principle of the pressing mechanism is as follows: adding half weight of particles B into a pressure cavity 5 through a feed inlet B7 and a feed pipe B9 according to the mass ratio, carrying and sealing the bottom of the pressure cavity 5 by a lower pressure head 13 extending into the pressure cavity, synchronously rotating an upper rotary disc 2 and a lower rotary disc 3 to enable an upper pressure rod 10 to correspond to the pressure cavity 5, extending the upper pressure rod 10 to press and form the B sheets, synchronously rotating the upper rotary disc 2 and the lower rotary disc 3 to enable the pressure cavity 5 and the feed pipe A8 to correspond to each other, adding the particles A according to the mass ratio, repeating the steps for pressing, synchronously rotating the upper rotary disc 2 and the lower rotary disc 3 to enable the pressure cavity 5 and the feed pipe B9 to correspond to each other, adding the remaining weight of particles B, repeating the steps for pressing, and pressing into B + A + B sheets, namely the composition tablet.
The composition tablet of the invention is tested, and the test items are as follows: lead (in Pb), total number of colonies, coliform group, salmonella; the detection basis is as follows: GB 17399-2016 (national standards for food safety) candy, GB 2762-2017 (national standards for food safety) pollutant limit in food, and SB-T10347-2017 (candy tabletting candy) requirements. The detection results are shown in table 5, where n is the number of samples to be collected from the same batch of product, c is the maximum allowable number of samples exceeding the value of M, M is the limit value of acceptable level of the microorganism index, and M is the maximum safety limit value of the microorganism index.
Experimental example: blood sugar test in mice
Selecting 12 healthy female mice with blood sugar less than 11.1mmol/L and the weight of 19-23g, adaptively feeding for one week, dividing the mice into four groups, each group comprising 3 mice, wherein the feeding environment temperature is 22-26 ℃, the relative humidity is 55-65%, the mice drink purified water, the feed is experimental mouse granular feed, and the experimental period is 7d.
In the first group, water is drunk every day, diet is not limited, blood sugar values of the tail tip blood of the white mouse are detected once every 10 o 'clock and 23 o' clock, and the average value of the blood sugar values of 3 white mice is obtained as a result.
In the second group, water is taken every day, diet is not limited, the composition A is fed to the white mice at 8 points every day, the dosage of the white mice is 0.6g/Kg, blood sugar values of the tail tip blood of the white mice are detected at 10 points and 23 points every day, and the average value of the blood sugar values of 3 white mice is taken as a result.
In the third group, water is drunk every day, diet is not limited, the composition B is fed to the white mice once every 8 o ' clock, the dosage of the white mice is 0.725g/Kg, blood sugar values of the tail tip blood of the white mice are detected once every 10 o ' clock and 23 o ' clock respectively, and the average value of the blood sugar values of 3 white mice is taken as a result.
And in the fourth group, drinking water and diet are not limited, and the composition A and the composition B are fed to the white mice at 8 points per day, wherein the dosage of the white mice is as follows: the blood sugar value of the tail tip blood of the white mouse is measured by extracting the blood of the tail tip of the white mouse once at 10 and 23 points every day, and the result is the average value of the blood sugar values of 3 white mice.
The detection results are shown in the following tables 1-4, wherein the blood sugar value of the white mouse in the first group is shown in the table 1, the blood sugar value of the white mouse in the second group is shown in the table 2, the blood sugar value of the white mouse in the third group is shown in the table 3, and the blood sugar value of the white mouse in the fourth group is shown in the table 4, and the unit is mmol/L; the results show that the blood sugar reducing effect of the invention is maintained for more than 12 hours, and the sustained release effect is achieved.
TABLE 1
TABLE 2
TABLE 3
TABLE 4
TABLE 5
Claims (10)
1. The protein peptide glucose-benefiting composition is characterized by comprising a composition A and a composition B, wherein the composition A consists of the following components: ginseng powder, oat beta-glucan, turmeric, wheat oligopeptide, earthworm protein and brown algae extract; composition B consisted of the following ingredients: sorbitol, alkyl propyl methyl cellulose, polyethylene glycol, rhizoma Amorphophalli powder, fructus Momordicae Charantiae extract, herba Picrasmae extract, cortex Cinnamomi powder, radix Puerariae extract, semen Ginkgo extract, herba Taraxaci extract, rhizoma Polygonati Odorati extract, and Poria extract.
2. The protein peptide glucose-benefiting composition according to claim 1, wherein the composition A comprises the following components in parts by weight: 5-10 parts of ginseng powder, 12-16 parts of oat beta-glucan, 6-11 parts of turmeric, 7-13 parts of wheat oligopeptide, 15-20 parts of earthworm protein and 18-26 parts of brown algae extract.
3. The protein peptide glucose-benefiting composition according to claim 2, wherein the composition a consists of the following components in parts by weight: 7 parts of ginseng powder, 14 parts of oat beta-glucan, 6 parts of turmeric, 10 parts of wheat oligopeptide, 20 parts of earthworm protein and 25 parts of brown algae extract.
4. The protein peptide glucose-benefiting composition according to claim 1, wherein the composition B comprises the following components in parts by weight: 4-8 parts of sorbitol, 2-6 parts of hydroxypropyl methyl cellulose, 1-3 parts of polyethylene glycol, 10-15 parts of konjaku flour, 7-10 parts of bitter gourd extract, 13-19 parts of bitter mustard extract, 5-10 parts of cinnamon powder, 9-13 parts of kudzu root extract, 8-16 parts of ginkgo extract, 16-20 parts of dandelion extract, 22-26 parts of polygonatum extract and 17-20 parts of poria cocos extract.
5. The protein peptide glucose-benefiting composition according to claim 4, wherein the composition B comprises the following components in parts by weight: 5 parts of sorbitol, 4 parts of alkyl propyl methyl cellulose, 3 parts of polyethylene glycol, 11 parts of konjac flour, 7 parts of bitter gourd extract, 19 parts of bitter mustard extract, 9 parts of cinnamon powder, 12 parts of kudzu root extract, 15 parts of ginkgo biloba extract, 20 parts of dandelion extract, 22 parts of polygonatum extract and 18 parts of poria cocos extract.
6. A method of preparing a protein peptide glucose-benefiting composition according to any one of claims 1 to 5, comprising the steps of:
step one, crushing, mixing and screening raw materials of the composition A through a 80-mesh sieve, putting the mixture into a swing granulator for granulation to obtain granules A, and drying the granules A for later use;
step two, crushing, mixing and sieving the raw materials of the composition B by a sieve of 80 meshes, putting the mixture into a swing granulator for granulation to obtain granules B, and drying the granules B for later use;
step three, taking the mass ratio of 1-1.5:1, adding half weight of the particles B into a pressing mechanism according to the mass ratio, pressing into B tablets, adding the particles A according to the mass ratio, pressing into A + B tablets, adding the rest weight of the particles B, pressing into B + A + B tablets, coating, packaging, inspecting and warehousing.
7. The method for preparing the protein peptide sugar-benefiting composition according to claim 6, wherein the pressing mechanism comprises a frame, an upper rotating disk and a lower rotating disk driven by the same power source, a feed port is formed in the frame, a pressing cavity corresponding to the feed port is formed in the upper rotating disk, and the feed port consists of a feed port A and a feed port B; wherein, be equipped with the depression bar in the frame, the lower extreme of going up the depression bar is equipped with the pressure head, is equipped with depression bar down on the lower carousel, and the upper end of depression bar is equipped with down the pressure head, goes up the depression bar and the depression bar corresponds the setting with same pressure chamber respectively, makes pressure head and lower pressure head can be impressed and press the chamber and with the shape phase-match that presses the chamber.
8. The method for preparing a protein peptide sugar-benefiting composition according to claim 7, wherein the upper rotating disk and the lower rotating disk are connected to a rotating shaft, and the rotating shaft is driven by a same power source to rotate, so as to drive the upper rotating disk and the lower rotating disk to rotate synchronously.
9. The method of claim 7, wherein the feed inlet A and the feed inlet B are connected to the feed inlet A and the feed inlet B, respectively.
10. The method according to claim 7, wherein the lower turntable is further provided with a blower, an air outlet of the blower is disposed corresponding to a lowest position of the lower pressure head, and the pressing mechanism further comprises a lower hopper disposed corresponding to an outer edge of the lower turntable.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211632018.4A CN115812959A (en) | 2022-12-19 | 2022-12-19 | Protein peptide glucose-benefiting composition and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211632018.4A CN115812959A (en) | 2022-12-19 | 2022-12-19 | Protein peptide glucose-benefiting composition and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115812959A true CN115812959A (en) | 2023-03-21 |
Family
ID=85516611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211632018.4A Pending CN115812959A (en) | 2022-12-19 | 2022-12-19 | Protein peptide glucose-benefiting composition and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115812959A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN202573048U (en) * | 2012-06-06 | 2012-12-05 | 江门瑞怡乐甜味剂厂有限公司 | Multi-head pressing-sheet type full-automatic high-efficiency rotary preforming press |
| WO2015127874A1 (en) * | 2014-02-25 | 2015-09-03 | 湖南希尔天然药业有限公司 | Traditional chinese medicine composition for treating type ii diabetes, and preparation and uses thereof |
| CN208497761U (en) * | 2018-05-29 | 2019-02-15 | 天津市壹杯红生物技术有限公司 | A kind of pharmaceutical rotary pelleting machine |
| CN110693028A (en) * | 2019-10-25 | 2020-01-17 | 陕西中鸿科瑞再生医学研究院有限公司 | Composition for reducing blood sugar and fat |
| CN110731509A (en) * | 2019-12-07 | 2020-01-31 | 张志红 | A health product containing prebiotics for lowering blood sugar and blood lipid, and its preparation method |
| CN110839805A (en) * | 2019-11-22 | 2020-02-28 | 坤承(北京)健康管理有限公司 | Plant solid beverage |
| CN111728214A (en) * | 2020-08-13 | 2020-10-02 | 珠海市天顺保健食品有限公司 | Medicinal and edible composition for assisting in reversing diabetes |
-
2022
- 2022-12-19 CN CN202211632018.4A patent/CN115812959A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN202573048U (en) * | 2012-06-06 | 2012-12-05 | 江门瑞怡乐甜味剂厂有限公司 | Multi-head pressing-sheet type full-automatic high-efficiency rotary preforming press |
| WO2015127874A1 (en) * | 2014-02-25 | 2015-09-03 | 湖南希尔天然药业有限公司 | Traditional chinese medicine composition for treating type ii diabetes, and preparation and uses thereof |
| CN208497761U (en) * | 2018-05-29 | 2019-02-15 | 天津市壹杯红生物技术有限公司 | A kind of pharmaceutical rotary pelleting machine |
| CN110693028A (en) * | 2019-10-25 | 2020-01-17 | 陕西中鸿科瑞再生医学研究院有限公司 | Composition for reducing blood sugar and fat |
| CN110839805A (en) * | 2019-11-22 | 2020-02-28 | 坤承(北京)健康管理有限公司 | Plant solid beverage |
| CN110731509A (en) * | 2019-12-07 | 2020-01-31 | 张志红 | A health product containing prebiotics for lowering blood sugar and blood lipid, and its preparation method |
| CN111728214A (en) * | 2020-08-13 | 2020-10-02 | 珠海市天顺保健食品有限公司 | Medicinal and edible composition for assisting in reversing diabetes |
Non-Patent Citations (1)
| Title |
|---|
| 王沛: "《药物制剂设备》", pages: 101 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104026446B (en) | A kind of it is suitable for nutritional meal replacement powder that hyperglycemia population takes and preparation method thereof | |
| CN100562259C (en) | A kind of health caring noodles and preparation method thereof with function of stabilizing body blood sugar after meal | |
| CN100579395C (en) | Instant nutritive gruel having a function of stabilizing body blood sugar after meal and method for preparing the same | |
| CN105077236B (en) | Compound special meals nutrient powder of the highland barley of auxiliary hyperglycemic and preparation method thereof | |
| CN106692297B (en) | Composition for assisting in reducing blood sugar and preparation method and application thereof | |
| CN106666312A (en) | Health-care food for assisting blood glucose decreasing and preparation method of granule and capsule thereof | |
| CN101317666A (en) | High-efficiency composite food cellulose and preparation method thereof | |
| CN105211853A (en) | Blood sugar reducing health composition, electuary and preparation method thereof | |
| CN109393494A (en) | A kind of person in middle and old age's health-care food composition and its application | |
| CN102907606B (en) | Beta-glucan composition and application thereof | |
| CN108523126A (en) | It is a kind of that there is the composition and preparation method thereof for improving blood glucose level | |
| CN100584215C (en) | Health rice with stable blood sugar content after meal and its production process | |
| CN102613453B (en) | Marine organism type enteral nutrition preparation for diabetes patients, preparation method of marine organism type enteral nutrition preparation and application | |
| CN101416743B (en) | Potentilla anserina L. rice flour food and production method thereof | |
| CN106474083B (en) | Sweet Qi sugar is rather without sugar chawing tablet and its preparation process and application | |
| CN1280008A (en) | Strong anti-oxidative composite capsule of grape seed extract OPC and its producing method | |
| CN110731509A (en) | A health product containing prebiotics for lowering blood sugar and blood lipid, and its preparation method | |
| CN115812959A (en) | Protein peptide glucose-benefiting composition and preparation method thereof | |
| CN100484539C (en) | Functional food with blood sugar reducing action and its preparing method | |
| CN115474691A (en) | Medicinal and edible nutritious food for reducing blood sugar of diabetes and preparation method thereof | |
| CN101422569B (en) | Health-care preparation capable of increasing the multiplication function of marrow hemopoietic stem cells to fight against senium and anaemia | |
| CN108208655A (en) | A kind of pure natural functional food with lower hyperlipidemia, hypertension, hyperglycemia and preparation method thereof | |
| CN1123097A (en) | "Jiangtanghu" and its production technology | |
| CN1135856A (en) | Health-care food for diabetes and its production | |
| CN102823813A (en) | Traditional Chinese medicine buckwheat instant noodle for diabetic patients to eat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |